Search for other papers by Niels B Dalsgaard in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Lærke S Gasbjerg in
Google Scholar
PubMed
Search for other papers by Laura S Hansen in
Google Scholar
PubMed
Search for other papers by Dennis S Nielsen in
Google Scholar
PubMed
Search for other papers by Torben S Rasmussen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
course with the alpha-glucosidase inhibitor, acarbose, on GM profiles (evaluated by 16S rRNA gene-based high-throughput sequencing) in Caucasian individuals with metformin-treated T2D. Materials and methods Ethics and study approvals This
Turku PET Centre, University of Turku, Turku, Finland
Search for other papers by Jukka Koffert in
Google Scholar
PubMed
Search for other papers by Henri Honka in
Google Scholar
PubMed
Search for other papers by Jarmo Teuho in
Google Scholar
PubMed
Search for other papers by Saila Kauhanen in
Google Scholar
PubMed
Search for other papers by Saija Hurme in
Google Scholar
PubMed
Department of Radiology, University of Turku and Turku University Hospital, Turku, Finland
Search for other papers by Riitta Parkkola in
Google Scholar
PubMed
Search for other papers by Vesa Oikonen in
Google Scholar
PubMed
Search for other papers by Andrea Mari in
Google Scholar
PubMed
Search for other papers by Andreas Lindqvist in
Google Scholar
PubMed
Search for other papers by Nils Wierup in
Google Scholar
PubMed
Search for other papers by Leif Groop in
Google Scholar
PubMed
Department of Endocrinology, Turku University Hospital, Turku, Finland
Search for other papers by Pirjo Nuutila in
Google Scholar
PubMed
of hepatic glucose cycling in glucose-intolerant or NIDDM patients . Diabetes 1991 40 73 – 81 . ( doi:10.2337/diab.40.1.73 ) 2 Holman RR. Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Research
The Center for Biomedical Research, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Search for other papers by Chunliang Yang in
Google Scholar
PubMed
Search for other papers by Junyi Li in
Google Scholar
PubMed
Search for other papers by Fei Sun in
Google Scholar
PubMed
Search for other papers by Haifeng Zhou in
Google Scholar
PubMed
Search for other papers by Jia Yang in
Google Scholar
PubMed
Search for other papers by Chao Yang in
Google Scholar
PubMed
enteral glucose absorption (alpha-glucosidase inhibitors) and increasing renal glucose excretion (SGLT-2 inhibitors). When mono-drug therapy fails, various combinations of drug administration are required for different clinical conditions. In worsened
Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed
Search for other papers by Feng Gu in
Google Scholar
PubMed
Search for other papers by Marcello D Bronstein in
Google Scholar
PubMed
Search for other papers by Thierry C Brue in
Google Scholar
PubMed
Search for other papers by Maria Fleseriu in
Google Scholar
PubMed
Search for other papers by Ilan Shimon in
Google Scholar
PubMed
Search for other papers by Aart J van der Lely in
Google Scholar
PubMed
Search for other papers by Shoba Ravichandran in
Google Scholar
PubMed
Search for other papers by Albert Kandra in
Google Scholar
PubMed
Search for other papers by Alberto M Pedroncelli in
Google Scholar
PubMed
Search for other papers by Annamaria A L Colao in
Google Scholar
PubMed
) OADs included dipeptidyl peptidase 4 inhibitors, sulfonylureas, meglitinides, thiazolidinediones and alpha-glucosidase inhibitors. Only two patients, both in the C2402 study, received a GLP-1 receptor agonist (liraglutide); these two patients were not
Search for other papers by Jonathan Hazlehurst in
Google Scholar
PubMed
Search for other papers by Bernard Khoo in
Google Scholar
PubMed
Department of Medicine, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark
Search for other papers by Carolina Brito Lobato in
Google Scholar
PubMed
Search for other papers by Ibiyemi Ilesanmi in
Google Scholar
PubMed
Search for other papers by Sally Abbott in
Google Scholar
PubMed
Search for other papers by Tin Chan in
Google Scholar
PubMed
Search for other papers by Sanesh Pillai in
Google Scholar
PubMed
Search for other papers by Kate Maslin in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK
Search for other papers by Sanjay Purkayastha in
Google Scholar
PubMed
Search for other papers by Barbara McGowan in
Google Scholar
PubMed
Search for other papers by Rob Andrews in
Google Scholar
PubMed
Search for other papers by Eveleigh Nicholson in
Google Scholar
PubMed
Search for other papers by Katherine McCullough in
Google Scholar
PubMed
Search for other papers by Lorraine Albon in
Google Scholar
PubMed
Search for other papers by Rachel Batterham in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Shareen Forbes in
Google Scholar
PubMed
Search for other papers by Gavin Bewick in
Google Scholar
PubMed
Search for other papers by Tricia M-M Tan in
Google Scholar
PubMed
MA . Post-gastric-bypass hypoglycemia successfully treated with alpha-glucosidase inhibitor therapy . Endocrine Practice 2013 19 511 – 514 . ( https://doi.org/10.4158/EP12281.RA ) 102 Cadegiani FA & Silva OS . Acarbose promotes remission of